Is XJUN or ABBV a better dividend investment in 2026?

XJUN currently yields 4.70% with a 5% 5-year dividend growth rate. ABBV yields 3.67% with 8.9% growth. The better choice depends on your goal: XJUN offers higher current income.

What is the dividend yield difference between XJUN and ABBV?

XJUN has a forward dividend yield of 4.70% ($2.00/share annually). ABBV yields 3.67% ($6.20/share annually). The yield gap is 1.03 percentage points.

Home › Compare › XJUN vs ABBV

XJUN vs ABBV: Dividend Comparison 2026

XJUN yields 4.70% · ABBV yields 3.67%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ABBV wins by $12.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

XJUN

● Live price

4.70%

Share price

$42.54

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.2K

Annual income

$635.31

Full XJUN calculator →

ABBV

AbbVie Inc.

● Live price

3.67%

Share price

$168.90

Annual div

$6.20

5Y div CAGR

8.9%

Payout ratio

58%

After 10 yrs · $10,000 · DRIP

Portfolio value

$39.9K

Annual income

$1,154.43

Full ABBV calculator →

Portfolio growth — XJUN vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XJUN	ABBV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XJUN + ABBV cover 4 of 12 months — good coverage

Jan

ABBV

Feb

—

Mar

—

Apr

ABBV

May

—

Jun

—

Jul

ABBV

Aug

—

Sep

—

Oct

ABBV

Nov

—

Dec

—

XJUN pays

ABBV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XJUN

Annual income on $10K today (after 15% tax)

$399.62/yr

After 10yr DRIP, annual income (after tax)

$540.01/yr

ABBV

Annual income on $10K today (after 15% tax)

$312.02/yr

After 10yr DRIP, annual income (after tax)

$981.27/yr

At 15% tax rate, ABBV beats the other by $441.25/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XJUN + ABBV for your $10,000?

XJUN: 50%ABBV: 50%

100% ABBV50/50100% XJUN

Portfolio after 10yr

$33.6K

Annual income

$894.87/yr

Blended yield

2.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

XJUN

No analyst data

ABBV

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$256.15

+51.7% upside vs current

Range: $223.00 — $299.00

Altman Z

2.0

Piotroski

8/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XJUN buys

ABBV buys

No recent congressional trades found for XJUN or ABBV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXJUNABBV

Forward yield	4.70% ✓	3.67%
Annual dividend / share	$2.00	$6.20 ✓
Payout ratio	50% ✓	58%
1-year div growth	0%	4.7% ✓
5-year div CAGR	0%	8.9% ✓
Portfolio after 10y	$27.2K	$39.9K ✓
Annual income after 10y	$635.31	$1,154.43 ✓
Total dividends collected	$5.6K	$7.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: XJUN vs ABBV ($10,000, DRIP)

Year	XJUN Portfolio	XJUN Income/yr	ABBV Portfolio	ABBV Income/yr	Gap
1← crossover	$11,170	$470.15	$11,520	$399.75	$350.00 → ABBV
2	$12,443	$490.80	$13,261	$450.98	$818.00 → ABBV
3	$13,825	$510.96	$15,255	$508.41	$1.4K → ABBV
4	$15,323	$530.57	$17,536	$572.74	$2.2K → ABBV
5	$16,945	$549.60	$20,145	$644.78	$3.2K → ABBV
6	$18,700	$568.02	$23,126	$725.38	$4.4K → ABBV
7	$20,594	$585.82	$26,532	$815.52	$5.9K → ABBV
8	$22,639	$602.97	$30,420	$916.26	$7.8K → ABBV
9	$24,843	$619.47	$34,855	$1,028.80	$10.0K → ABBV
10	$27,217	$635.31	$39,914	$1,154.43	$12.7K → ABBV

XJUN vs ABBV: Complete Analysis 2026

XJUN — Stock

The investment objective of the FT Vest U.S. Equity Enhance & Moderate Buffer ETF - June (the "Fund") is to seek to provide investors with returns (before fees and expenses) of approximately twice any positive price return of the SPDR S&P 500 ETF Trust (the "Underlying ETF"), up to a predetermined upside cap of 10.58% while providing a buffer (before fees and expenses) against the first 15% of Underlying ETF losses, over the period from June 23, 2025 to June 18, 2026.

Full XJUN Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

📬

Get this XJUN vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XJUN vs SCHD XJUN vs JEPI XJUN vs O XJUN vs KO XJUN vs MAIN XJUN vs JNJ XJUN vs MRK XJUN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.